Literature DB >> 22850881

Take a deep breath: pulmonary research inspires.

Paul W Noble1.   

Abstract

The lung is a complex organ with multiple functions; in addition to facilitating gas exchange, it also serves as the first line of defense against inhaled environmental pathogens and toxins. Given these critical roles, disruption of normal cell function or cell-cell interactions can have devastating health consequences. The articles of this Review Series highlight recent progress in understanding the pathophysiology of several pulmonary diseases and suggest how these insights are leading to the development of new therapeutic strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22850881      PMCID: PMC3408760          DOI: 10.1172/JCI65404

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  8 in total

Review 1.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management.

Authors:  Michael A Matthay; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10       Impact factor: 6.914

Review 2.  Building and maintaining the epithelium of the lung.

Authors:  Craig R Rackley; Barry R Stripp
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 3.  The acute respiratory distress syndrome.

Authors:  Michael A Matthay; Lorraine B Ware; Guy A Zimmerman
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

4.  Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Authors:  Paul W Noble; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Marilyn K Glassberg; David Kardatzke; Talmadge E King; Lisa Lancaster; Steven A Sahn; Javier Szwarcberg; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2011-05-13       Impact factor: 79.321

5.  Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.

Authors:  Talmadge E King; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Phil Hormel; Lisa Lancaster; Paul W Noble; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Roland M du Bois
Journal:  Lancet       Date:  2009-06-29       Impact factor: 79.321

Review 6.  Pulmonary fibrosis: patterns and perpetrators.

Authors:  Paul W Noble; Christina E Barkauskas; Dianhua Jiang
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 7.  Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens.

Authors:  Michael J Holtzman
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

Review 8.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  Rubin M Tuder; Irina Petrache
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.